Pharmaceutical Drug Regulatory Affairs Journal (PDRAJ)

ISSN: 2642-6315

Review Article

Filing of DMF in US, Canada & Europe

Authors: Yamini SPK*, Jain N, Chandra A, Shukla VK, Bansal A and Kumar S

DOI: 10.23880/pdraj-16000108

Abstract

DMF (Drug Master File) it is a kind of confidential document which contains complete, factual and correct information about active pharmaceutical ingredient or finished drug dosage form. A DMF can be used by holder who establishes the file or by one or more parties in support of their files or applications. The Drug master file consist of 2 parts: (a) the applicant’s part – that contains all the information that the license holder needs to review about quality of drug product & (b) the restricted part – which contains all the confidential information about the manufacturing process that can only be presented in front of authorities. The purpose of this article is to present an overview of DMF filing in different countries which are USA, CANADA, and EUROPE. In USA, CANADA the drug master file is known as DMF only but in EUROPE it is known as ASMF (active substance master file).

Keywords: DMF; US; Europe; Canada

View PDF

Google_Scholar_logo Academic Research index asi ISI_logo logo_wcmasthead_en scilitLogo_white F1 search-result-logo-horizontal-TEST cas_color europub infobase logo_world_of_journals_no_margin